Now FDAnews and MHP Consultants are offering an interactive workshop that answers all these questions and much more ... AND gives you the tools you need for full compliance with FDA and international regulations on managing and reducing GxP deviations — over the entire investigation life cycle.
At Managing and Reducing Drug and Device GxP Deviations workshop, you will discover how to:
From enterprise-level companies to the smallest start-up, no firm is safe from GxP deviation warning letters, including yours. Protect your investigation from start to finish: Register for this attendee-focused workshop today!
Exclusive Attendee-Focused Workshop
Unlike the one-size-fits-all workshops that you may have attended, Managing and Reducing GxP Deviations is built around you.
Here's how it works. Fill out the exclusive pre-workshop survey (you'll receive it once you register) for two days of:
Bottom line? For targeted material ... top value ... and true networking, sign up for Managing and Reducing GxP Deviations — the workshop that's focused on you.
Your valuable course materials book is packed with tools and reference data you can put to use right away, including:
Michele Piepoli, president of MHP Consultants, has more than 35 years of experience in the industry. During the past eight years, Michele has been actively involved in implementation of quality systems within the pharma industry. Michele has led quality projects in the domestic and international community.
She previously served as director of Shuster Laboratories' Pharmaceutical Division, where she was responsible for fiscal and technical operations as well as assuring full regulatory compliance of the facility. Her laboratory expertise includes chromatography, spectroscopy, method development/validation and instrumentation validation.
Michele has extensive experience in developing and presenting compliance training seminars, conducting facility audits and playing a key role in the development and implementation of quality systems.
Early — Space is Limited
Hurry — register early because space is limited! Your tuition of $1,897 per attendee includes the two-day workshop, all conference materials, continental breakfast and lunch each day. Payment is required by the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Your Team for Maximum Benefit
Written cancellations received at least 21 calendar days prior to the start date of the event will receive a refund — less a $200 administration fee. No cancellations will be accepted — nor refunds issued — within 21 calendar days from the start date of the event. A credit for the amount paid may be transferred to any future FDAnews event. Substitutions may be made at any time. No-shows will be charged the full amount. In the event that FDAnews cancels the event, FDAnews is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.
Exhibit and Sponsorship Opportunities
For exhibit and sponsorship opportunities at this event, please contact:
Phone: +1 (703) 538-7643 • Fax: +1 (703) 538-5000
Interested in becoming a speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews physical conference, webinar or audioconference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.
Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing